Circulating Tumor Cells Global Market Report 2025

Global Circulating Tumor Cells Market Report 2024

Circulating Tumor Cells Global Market Report 2025 – By Product (Kits And Reagents, Blood Collection Tubes, Devices Or Systems), By Technology (CTC Enrichment, CTC Detection, CTC Analysis), By Specimen (Blood, Bone Marrow, Other Body Fluids), By Application (Clinical Or Liquid Biopsy, Research) – Market Size, Trends, And Global Forecast 2025-2034

Name: Circulating Tumor Cells Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Circulating Tumor Cells Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Circulating Tumor Cells Global Market Report 2025

Proud Members Of

Circulating Tumor Cells Market Definition

Circulating tumor cells refer to solid tumor-derived cells that have shed from the primary tumor and are extravasated into the blood circulation system. They are used as a tool to diagnose and prognosis of cancer.

The main products of circulating tumor cells include kits and reagents, blood collection tubes and devices or systems. Kits and reagents are a complete set of consumables that include a blood specimen separator, proprietary microfluidic capture chip, CTC enrichment, and immunostaining reagents. They are collected using different specimens of a human body including blood, bone marrow and other body fluids by using different technologies such as CTC enrichment, CTC detection and CTC analysis that are used for clinical or liquid biopsy and research applications.

Circulating Tumor Cells Market Segmentation

The circulating tumor cells market covered in this report is segmented –

1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems

2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis

3) By Specimen: Blood, Bone Marrow, Other Body Fluids

4) By Application: Clinical Or Liquid Biopsy, Research

Subsegments:

1) By Kits And Reagents: Cell Enrichment Kits, Detection Kits, Nucleic Acid Isolation Kits

2) By Blood Collection Tubes: Standard Blood Collection Tubes, Specialized Blood Collection Tubes

3) By Devices Or Systems: Microfluidic Devices, Automated Cell Capture Systems, Imaging Systems

Circulating Tumor Cells Global Market Report 2025 Market Size and growth rate 2025 to 2029: Graph

Circulating Tumor Cells Market Size 2025 And Growth Rate

The circulating tumor cells market size has grown rapidly in recent years. It will grow from $11.9 billion in 2024 to $13.37 billion in 2025 at a compound annual growth rate (CAGR) of 12.4%. The growth in the historic period can be attributed to cancer incidence and prevalence, clinical utility in cancer staging, emergence of liquid biopsy, patient demand for minimally invasive tests, regulatory support for liquid biopsies, focus on early cancer detection.

Circulating Tumor Cells Market Growth Forecast

The circulating tumor cells market size is expected to see rapid growth in the next few years. It will grow to $21.68 billion in 2029 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to point-of-care CTC testing, adoption of microfluidics, focus on rare cancer types, standardization of CTC assays, expansion of CTC-based clinical trials, economic and emerging market growth. Major trends in the forecast period include innovations in CTC isolation techniques, government funding for CTC research, advancements in CTC detection technologies, liquid biopsy for cancer monitoring, integration with single-cell analysis, technological convergence with artificial intelligence (AI).

Book your 30 minutes free consultation with our research experts

Circulating Tumor Cells Market Driver: Rising Cancer Incidence Drives Surge In Circulating Tumor Cells Market

The growing incidence of cancer is expected to propel the circulating tumor cells market growth going forward. Cancer refers to a disease in which a few body cells grow uncontrollably and spread to other parts. Circulating tumor cells are used to help in the early detection and diagnosis of cancer, and thus growing incidence of cancer propels the growth of the circulating tumor cells market. For instance, in January 2023, the American Cancer Society Journals, a US-based voluntary health organization, projected that 1,958,310 new cancer cases would be diagnosed, with 609,820 cancer-related deaths expected in the United States. Therefore, the growing incidence of cancer is driving the growth of the circulating tumor cells market.

Circulating Tumor Cells Market Driver: Rising Adoption Of Circulating Tumor Cells In Clinical Trials Is A Catalyst For Market Growth

The increasing adoption in clinical trials is expected to propel the growth of the circulating tumor cells market growth going forward. Clinical trials are research studies conducted to evaluate the safety, efficacy, and effectiveness of new medical treatments, interventions, or procedures in humans. The integration of circulating tumor cells (CTC) analysis in clinical trials enhances the ability to assess treatment response, early detection and monitoring, tailor interventions to specific patient profiles, and improve the overall efficiency and to validate clinical endpoints. For instance, in May 2023, according to Xtalks, a Canada-based company specializing in providing life science webinars and virtual events, there are 452,604 clinical studies that have been registered on ClinicalTrials.gov as of May 17, 2023. 64,838 studies out of the total number that have been registered are actively seeking participants which is an increase of 365,000 registered trials in 2021. Therefore, the increasing adoption in clinical trials is driving the growth of the circulating tumor cells market.

Global Circulating Tumor Cells Market Major Players

Major companies operating in the circulating tumor cells market include Precision Medicine Group LLC, Bio-Techne Corporation, BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., Qiagen N.V., ScreenCell SAS, STEMCELL Technologies Inc., Sysmex Corporation, Aviva Biosciences Corporation, LungLife AI Inc., Miltenyi Biotec GmbH, Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, LineaRx Inc., Thermo Fisher Scientific Inc., Greiner Bio-One International GmbH, Stanford Research Institute International, Agilent Technologies Inc., Resolution Bioscience Inc., Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd.

Global Circulating Tumor Cells Market Trend: The Surge Of Product Innovations In The Circulating Tumor Cells Market

Product innovations are a key trend gaining popularity in the circulating tumor cells market. Major companies operating in the circulating tumor cells market are focused on developing innovative products to strengthen their position in the market. For instance, in June 2024, Bio-Rad Laboratories, Inc., a US-based medical laboratory, launched the Celselect Slides 2.0. It is designed to enhance the capture of rare cells and circulating tumor cells (CTCs), improving the accuracy and efficiency of cell analysis for clinical and research applications.

Global Circulating Tumor Cells Market Trend: Increasing Focus On Liquid Biopsy Products To Provide Reliable Services To Their Customers

Major companies operating in the circulating tumor cells market are focusing on innovative products such as oncology liquid biopsy products to drive revenues in their market. Liquid biopsy in oncology refers to a minimally invasive or non-invasive technique used to identify and track disease biomarkers in bodily fluids such as sputum, blood, and urine. For instance, in June 2022, BillionToOne Inc., a US-based biotech company specializing in molecular diagnostics, launched oncology liquid biopsy products, NorthStar Select and NorthStar Response. NorthStar Select is a thorough somatic mutation profiling panel for cancer. The panel identifies actionable mutations with a noteworthy limit of detection because of BillionToOne's exclusive molecular counting method, known as quantitative counting templates (QCTs). NorthStar Response is a tissue-neutral, methylation-based treatment response monitoring test. The assay gives an exact estimate of the burden of methylation circulating tumor DNA (ctDNA) using molecular counting technologies.

Circulating Tumor Cells Market Merger And Acquisition: Cell Microsystems Expands Cell Analysis Expertise with Acquisition of Fluxion Biosciences

In August 2023, Cell Microsystems, a US-based biotechnology company, acquired Fluxion Biosciences for an undisclosed amount. This acquisition aims to enhance Cell Microsystems' capabilities in cell analysis and provide advanced solutions for research and clinical applications. Fluxion Biosciences is a US-based company, specializes in technologies for isolating and analyzing circulating tumor cells (CTCs).

Regional Analysis For The Global Circulating Tumor Cells Market

North America was the largest region in the circulating tumor cells market in 2024. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the circulating tumor cells market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Circulating Tumor Cells Market?

The circulating tumor cells market consists of sales of clinical samples, KRT7, PSMA positive cells, and TTF-1 positive. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Circulating Tumor Cells Industry?

The circulating tumor cells market research report is one of a series of new reports from The Business Research Company that provides circulating tumor cells market statistics, including circulating tumor cells industry global market size, regional shares, competitors with a circulating tumor cells market share, detailed circulating tumor cells market segments, market trends and opportunities, and any further data you may need to thrive in the circulating tumor cells industry. This circulating tumor cells market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Circulating Tumor Cells Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$13.37 billion
Revenue Forecast In 2034	$21.68 billion
Growth Rate	CAGR of 12.8% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems 2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis 3) By Specimen: Blood, Bone Marrow, Other Body Fluids 4) By Application: Clinical Or Liquid Biopsy, Research Subsegments: 1) By Kits And Reagents: Cell Enrichment Kits, Detection Kits, Nucleic Acid Isolation Kits 2) By Blood Collection Tubes: Standard Blood Collection Tubes, Specialized Blood Collection Tubes 3) By Devices Or Systems: Microfluidic Devices, Automated Cell Capture Systems, Imaging Systems
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Precision Medicine Group LLC, Bio-Techne Corporation, BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., Qiagen N.V., ScreenCell SAS, STEMCELL Technologies Inc., Sysmex Corporation, Aviva Biosciences Corporation, LungLife AI Inc., Miltenyi Biotec GmbH, Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, LineaRx Inc., Thermo Fisher Scientific Inc., Greiner Bio-One International GmbH, Stanford Research Institute International, Agilent Technologies Inc., Resolution Bioscience Inc., Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Circulating Tumor Cells Market Characteristics

3. Circulating Tumor Cells Market Trends And Strategies

4. Circulating Tumor Cells Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Circulating Tumor Cells Growth Analysis And Strategic Analysis Framework

5.1. Global Circulating Tumor Cells PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Circulating Tumor Cells Market Growth Rate Analysis

5.4. Global Circulating Tumor Cells Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Circulating Tumor Cells Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Circulating Tumor Cells Total Addressable Market (TAM)

6. Circulating Tumor Cells Market Segmentation

6.1. Global Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Kits And Reagents

Blood Collection Tubes

Devices Or Systems

6.2. Global Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

CTC Enrichment

CTC Detection

CTC Analysis

6.3. Global Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Blood

Bone Marrow

Other Body Fluids

6.4. Global Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Clinical Or Liquid Biopsy

Research

6.5. Global Circulating Tumor Cells Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cell Enrichment Kits

Detection Kits

Nucleic Acid Isolation Kits

6.6. Global Circulating Tumor Cells Market, Sub-Segmentation Of Blood Collection Tubes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Standard Blood Collection Tubes

Specialized Blood Collection Tubes

6.7. Global Circulating Tumor Cells Market, Sub-Segmentation Of Devices Or Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Microfluidic Devices

Automated Cell Capture Systems

Imaging Systems

7. Circulating Tumor Cells Market Regional And Country Analysis

7.1. Global Circulating Tumor Cells Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Circulating Tumor Cells Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Circulating Tumor Cells Market

8.1. Asia-Pacific Circulating Tumor Cells Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Circulating Tumor Cells Market

9.1. China Circulating Tumor Cells Market Overview

9.2. China Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Circulating Tumor Cells Market

10.1. India Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Circulating Tumor Cells Market

11.1. Japan Circulating Tumor Cells Market Overview

11.2. Japan Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Circulating Tumor Cells Market

12.1. Australia Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Circulating Tumor Cells Market

13.1. Indonesia Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Circulating Tumor Cells Market

14.1. South Korea Circulating Tumor Cells Market Overview

14.2. South Korea Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Circulating Tumor Cells Market

15.1. Western Europe Circulating Tumor Cells Market Overview

15.2. Western Europe Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Circulating Tumor Cells Market

16.1. UK Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Circulating Tumor Cells Market

17.1. Germany Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Circulating Tumor Cells Market

18.1. France Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Circulating Tumor Cells Market

19.1. Italy Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Circulating Tumor Cells Market

20.1. Spain Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Circulating Tumor Cells Market

21.1. Eastern Europe Circulating Tumor Cells Market Overview

21.2. Eastern Europe Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Circulating Tumor Cells Market

22.1. Russia Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Circulating Tumor Cells Market

23.1. North America Circulating Tumor Cells Market Overview

23.2. North America Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Circulating Tumor Cells Market

24.1. USA Circulating Tumor Cells Market Overview

24.2. USA Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Circulating Tumor Cells Market

25.1. Canada Circulating Tumor Cells Market Overview

25.2. Canada Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Circulating Tumor Cells Market

26.1. South America Circulating Tumor Cells Market Overview

26.2. South America Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Circulating Tumor Cells Market

27.1. Brazil Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Circulating Tumor Cells Market

28.1. Middle East Circulating Tumor Cells Market Overview

28.2. Middle East Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Circulating Tumor Cells Market

29.1. Africa Circulating Tumor Cells Market Overview

29.2. Africa Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Circulating Tumor Cells Market Competitive Landscape And Company Profiles

30.1. Circulating Tumor Cells Market Competitive Landscape

30.2. Circulating Tumor Cells Market Company Profiles

30.2.1. Precision Medicine Group LLC Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Bio-Techne Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.3. BIOCEPT Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Creativ MicroTech Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Fluxion Biosciences Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Circulating Tumor Cells Market Other Major And Innovative Companies

31.1. Ikonisys Inc.

31.2. Qiagen N.V.

31.3. ScreenCell SAS

31.4. STEMCELL Technologies Inc.

31.5. Sysmex Corporation

31.6. Aviva Biosciences Corporation

31.7. LungLife AI Inc.

31.8. Miltenyi Biotec GmbH

31.9. Menarini Silicon Biosystems S.p.A.

31.10. Canopus Bioscience Ltd.

31.11. IVDiagnostics Inc.

31.12. BioFluidica Inc.

31.13. Biolidics Limited

31.14. Rarecells Diagnostics SAS

31.15. LineaRx Inc.

32. Global Circulating Tumor Cells Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Circulating Tumor Cells Market

34. Recent Developments In The Circulating Tumor Cells Market

35. Circulating Tumor Cells Market High Potential Countries, Segments and Strategies

35.1 Circulating Tumor Cells Market In 2029 - Countries Offering Most New Opportunities

35.2 Circulating Tumor Cells Market In 2029 - Segments Offering Most New Opportunities

35.3 Circulating Tumor Cells Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Circulating Tumor Cells Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Circulating Tumor Cells Market, Sub-Segmentation Of Blood Collection Tubes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Circulating Tumor Cells Market, Sub-Segmentation Of Devices Or Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Circulating Tumor Cells Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Circulating Tumor Cells Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Precision Medicine Group LLC Financial Performance

Table 79: Bio-Techne Corporation Financial Performance

Table 80: BIOCEPT Inc. Financial Performance

Table 81: Creativ MicroTech Inc. Financial Performance

Table 82: Fluxion Biosciences Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Circulating Tumor Cells Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Circulating Tumor Cells Market, Sub-Segmentation Of Blood Collection Tubes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Circulating Tumor Cells Market, Sub-Segmentation Of Devices Or Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Circulating Tumor Cells Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Circulating Tumor Cells Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Circulating Tumor Cells Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Precision Medicine Group LLC Financial Performance

Figure 79: Bio-Techne Corporation Financial Performance

Figure 80: BIOCEPT Inc. Financial Performance

Figure 81: Creativ MicroTech Inc. Financial Performance

Figure 82: Fluxion Biosciences Inc. Financial Performance

Global Anesthesia Machines Market 2022 – Market Opportunities And Strategies

Latest Benign Prostatic Hyperplasia BPH Treatment Devices And Equipment Market Growth Study 2022-2026 By The Business Research Company

What Is The Computed Tomography CT Scanners Devices And Equipment Market Overview In 2022?

Global In-Vitro Diagnostics Market 2022 – Market Opportunities And Strategies

The Business Research Company offers the single use assemblies market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the temperature monitoring devices market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the urinary incontinence and pelvic organ prolapse devices and equipment market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the dental equipment and supplies market research report 2022 with industry size, share, segments and market growth

Cardiovascular Devices Global Market Report 2025 – By Type (Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment), By End User (Hospitals And Clinics, Diagnostic Laboratories, Other End Users), By Type of Expenditure (Public, Private), By Product (Instruments/Equipment, Disposables) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cardiovascular Surgery Devices And Equipment Global Market Report 2025 – By Product Type (Beating heart surgery systems, Cardiopulmonary Bypass Equipment, Cardiac Ablation Devices, Perfusion Disposables), By Application (Congenital Heart Defects, Cardiac Arrhythmia, Coronary Heart Disease, Congestive Heart Failure, Other Applications), By End User (Home and Ambulatory care, Hospitals, Diagnostic laboratories, Research laboratories) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Spinal Surgery Devices And Equipment Global Market Report 2025 – By Product Type (Non-Fusion Devices, Fusion Devices, Equipment), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Orthopedic And Spine Centers), By Type Of Surgery (Open Surgery And Minimally Invasive Surgery (MIS)) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Handheld Surgical Devices And Equipment Global Market Report 2025 – By Product (Scalpels, Forceps, Retractor, Dilators, Graspers, Other Products), By Application, Neurosurgery, Cardiovascular, Orthopedic, Plastic & Reconstructive Surgery, Obstetrics & Gynecology, Other Applications), By End-User (Hospitals, Specialized Clinics, Long-Term Care Centers, Ambulatory Surgery Centers, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Neurosurgery Devices And Equipment Global Market Report 2025 – By Device Type (Neuroendoscope, Stereotactic Systems, Aneurysm Clips, Neurostimulation Devices, Cerebrospinal Fluid Management Devices, Neurosurgical Evacuation Device, Neurosurgical Navigation Systems, Neurosurgery Surgical Power Tools, Others (Ultrasonic Aspirators, Surgical Instruments)), By Surgery Type (Intracranial Surgery, Endonasal Neurosurgery, Spinal Surgery), By End User (Hospitals, Ambulatory Surgical Centers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Robotic Surgery Devices Global Market Report 2025 – By Product (Robotic systems, Instruments & Accessories, Services), By Application (General Surgery, Urological Surgery, Gynecological Surgery, Orthopaedics Surgery, Neurosurgery And Other Applications), By End-Use (Hospitals And Ambulatory Surgery Centers (Ascs)) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Electrosurgical Devices And Equipment Global Market Report 2025 – By Product (Electrosurgery Generators, Electrosurgery Instruments & Accessories, Argon and Smoke Management Systems ), By Application (General Surgery, Gynecology Surgery, Urologic Surgery, Orthopedic Surgery, Cardiovascular Surgery, Cosmetic Surgery, Neurosurgery), By End User (Hospitals, Specialized Clinics, Ambulatory Surgery Centers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

ENT Surgical Devices And Equipment Global Market Report 2025 – By Product (Hand Instrument, ENT Surgical Lasers, Powered ENT Surgical Systems, Radiofrequency Electrosurgical Devices, ENT Surgery Workstations, ENT Surgical Navigation System, ENT Visualization System, Surgical Microscopes), By Modality (Hand-held devices, Portable devices, Fixed devices), By End User (Hospitals, Ambulatory surgical centers, ENT Clinics) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the circulating tumor cells market?

How will the circulating tumor cells market drivers and restraints affect the circulating tumor cells market dynamics? What forces will shape the circulating tumor cells industry going forward?

The circulating tumor cells market major growth driver - Circulating tumor cells refer to solid tumor-derived cells that have shed from the primary tumor and are extravasated into the blood circulation system. They are used as a tool to diagnose and prognosis of cancer.. For further insights on the circulating tumor cells market, request a sample here

What is the forecast market size or the forecast market value of the circulating tumor cells market?

The circulating tumor cells market size has grown rapidly in recent years. It will grow from $11.9 billion in 2024 to $13.37 billion in 2025 at a compound annual growth rate (CAGR) of 12.4%. The growth in the historic period can be attributed to cancer incidence and prevalence, clinical utility in cancer staging, emergence of liquid biopsy, patient demand for minimally invasive tests, regulatory support for liquid biopsies, focus on early cancer detection. The circulating tumor cells market size is expected to see rapid growth in the next few years. It will grow to $21.68 billion in 2029 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to point-of-care CTC testing, adoption of microfluidics, focus on rare cancer types, standardization of CTC assays, expansion of CTC-based clinical trials, economic and emerging market growth. Major trends in the forecast period include innovations in CTC isolation techniques, government funding for CTC research, advancements in CTC detection technologies, liquid biopsy for cancer monitoring, integration with single-cell analysis, technological convergence with artificial intelligence (AI). For further insights on the circulating tumor cells market, request a sample here

How is the circulating tumor cells market segmented?

The circulating tumor cells market is segmented
1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems
2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis
3) By Specimen: Blood, Bone Marrow, Other Body Fluids
4) By Application: Clinical Or Liquid Biopsy, Research Subsegments:
1) By Kits And Reagents: Cell Enrichment Kits, Detection Kits, Nucleic Acid Isolation Kits
2) By Blood Collection Tubes: Standard Blood Collection Tubes, Specialized Blood Collection Tubes
3) By Devices Or Systems: Microfluidic Devices, Automated Cell Capture Systems, Imaging Systems For further insights on the circulating tumor cells market, request a sample here

Which region has the largest share of the circulating tumor cells market? What are the other regions covered in the report?

North America was the largest region in the circulating tumor cells market in 2024. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the circulating tumor cells market, request a sample here.

Who are the major players in the circulating tumor cells market?

What are the key trends in the circulating tumor cells market?

Major trend in the circulating tumor cells market - The Surge Of Product Innovations In The Circulating Tumor Cells Market. For further insights on the circulating tumor cells market, request a sample here.

What are the major opportunities in the circulating tumor cells market? What are the strategies for the circulating tumor cells market?

For detailed insights on the major opportunities and strategies in the circulating tumor cells market, request a sample here.

How does the circulating tumor cells market relate to the overall economy and other similar markets?

For detailed insights on circulating tumor cells market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the circulating tumor cells industry?

For detailed insights on the mergers and acquisitions in the circulating tumor cells industry, request a sample here.

What are the key dynamics influencing the circulating tumor cells market growth? SWOT analysis of the circulating tumor cells market.

For detailed insights on the key dynamics influencing the circulating tumor cells market growth and SWOT analysis of the circulating tumor cells industry, request a sample here.